[HTML][HTML] Immunotherapy for Alzheimer's disease: Targeting β-amyloid and beyond
C Song, J Shi, P Zhang, Y Zhang, J Xu, L Zhao… - Translational …, 2022 - Springer
Alzheimer's disease (AD) is the most common neurodegenerative disease in the elderly
worldwide. However, the complexity of AD pathogenesis leads to discrepancies in the …
worldwide. However, the complexity of AD pathogenesis leads to discrepancies in the …
Immunotherapy for Alzheimer's disease: targeting β-amyloid and beyond.
C Song, J Shi, P Zhang, Y Zhang, J Xu… - Translational …, 2022 - search.ebscohost.com
Alzheimer's disease (AD) is the most common neurodegenerative disease in the elderly
worldwide. However, the complexity of AD pathogenesis leads to discrepancies in the …
worldwide. However, the complexity of AD pathogenesis leads to discrepancies in the …
Immunotherapy for Alzheimer's disease: targeting β-amyloid and beyond.
C Song, J Shi, P Zhang, Y Zhang, J Xu… - Translational …, 2022 - europepmc.org
Alzheimer's disease (AD) is the most common neurodegenerative disease in the elderly
worldwide. However, the complexity of AD pathogenesis leads to discrepancies in the …
worldwide. However, the complexity of AD pathogenesis leads to discrepancies in the …
[HTML][HTML] Immunotherapy for Alzheimer's disease: targeting β-amyloid and beyond
C Song, J Shi, P Zhang, Y Zhang, J Xu… - Translational …, 2022 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is the most common neurodegenerative disease in the elderly
worldwide. However, the complexity of AD pathogenesis leads to discrepancies in the …
worldwide. However, the complexity of AD pathogenesis leads to discrepancies in the …
Immunotherapy for Alzheimer's disease: targeting β-amyloid and beyond
C Song, J Shi, P Zhang, Y Zhang… - Translational …, 2022 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is the most common neurodegenerative disease in the elderly
worldwide. However, the complexity of AD pathogenesis leads to discrepancies in the …
worldwide. However, the complexity of AD pathogenesis leads to discrepancies in the …
[HTML][HTML] Immunotherapy for Alzheimer's disease: targeting β-amyloid and beyond
C Song, J Shi, P Zhang… - Translational …, 2022 - translationalneurodegeneration …
Alzheimer's disease (AD) is the most common neurodegenerative disease in the elderly
worldwide. However, the complexity of AD pathogenesis leads to discrepancies in the …
worldwide. However, the complexity of AD pathogenesis leads to discrepancies in the …
Immunotherapy for Alzheimer's disease: targeting β-amyloid and beyond.
C Song, J Shi, P Zhang, Y Zhang, J Xu… - Translational …, 2022 - europepmc.org
Alzheimer's disease (AD) is the most common neurodegenerative disease in the elderly
worldwide. However, the complexity of AD pathogenesis leads to discrepancies in the …
worldwide. However, the complexity of AD pathogenesis leads to discrepancies in the …
[HTML][HTML] Immunotherapy for Alzheimer's disease: targeting β-amyloid and beyond
C Song, J Shi, P Zhang… - Translational …, 2022 - translationalneurodegeneration …
Alzheimer's disease (AD) is the most common neurodegenerative disease in the elderly
worldwide. However, the complexity of AD pathogenesis leads to discrepancies in the …
worldwide. However, the complexity of AD pathogenesis leads to discrepancies in the …